Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 23 studies | 33% ± 13% | |
endothelial cell | 22 studies | 27% ± 11% | |
oligodendrocyte | 16 studies | 60% ± 22% | |
fibroblast | 15 studies | 21% ± 6% | |
oligodendrocyte precursor cell | 15 studies | 41% ± 17% | |
astrocyte | 14 studies | 38% ± 15% | |
monocyte | 11 studies | 25% ± 7% | |
classical monocyte | 11 studies | 26% ± 10% | |
microglial cell | 11 studies | 27% ± 8% | |
glutamatergic neuron | 10 studies | 40% ± 25% | |
GABAergic neuron | 9 studies | 44% ± 22% | |
myeloid cell | 9 studies | 31% ± 11% | |
pericyte | 9 studies | 24% ± 8% | |
endothelial cell of lymphatic vessel | 8 studies | 26% ± 7% | |
smooth muscle cell | 8 studies | 19% ± 4% | |
ciliated cell | 7 studies | 26% ± 9% | |
conventional dendritic cell | 6 studies | 23% ± 5% | |
interneuron | 6 studies | 44% ± 18% | |
epithelial cell | 6 studies | 35% ± 10% | |
adipocyte | 6 studies | 24% ± 6% | |
neutrophil | 5 studies | 20% ± 3% | |
neuron | 5 studies | 35% ± 21% | |
retinal bipolar neuron | 5 studies | 21% ± 4% | |
cardiac muscle cell | 5 studies | 26% ± 5% | |
non-classical monocyte | 4 studies | 25% ± 5% | |
mononuclear phagocyte | 4 studies | 28% ± 10% | |
granule cell | 4 studies | 22% ± 5% | |
retina horizontal cell | 4 studies | 25% ± 9% | |
retinal pigment epithelial cell | 4 studies | 25% ± 9% | |
dendritic cell | 4 studies | 25% ± 7% | |
connective tissue cell | 4 studies | 22% ± 4% | |
abnormal cell | 3 studies | 27% ± 11% | |
GABAergic interneuron | 3 studies | 35% ± 3% | |
glial cell | 3 studies | 24% ± 6% | |
retinal cone cell | 3 studies | 25% ± 4% | |
OFF-bipolar cell | 3 studies | 26% ± 7% | |
ON-bipolar cell | 3 studies | 44% ± 5% | |
amacrine cell | 3 studies | 26% ± 12% | |
glycinergic amacrine cell | 3 studies | 22% ± 7% | |
retinal rod cell | 3 studies | 22% ± 3% | |
endothelial cell of vascular tree | 3 studies | 25% ± 8% | |
ependymal cell | 3 studies | 47% ± 16% | |
myofibroblast cell | 3 studies | 25% ± 8% | |
alveolar macrophage | 3 studies | 36% ± 13% | |
chondrocyte | 3 studies | 32% ± 6% | |
basal cell | 3 studies | 28% ± 9% | |
renal principal cell | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2116.83 | 1445 / 1445 | 99% | 7.54 | 181 / 183 |
brain | 100% | 4382.17 | 2640 / 2642 | 98% | 11.38 | 693 / 705 |
lung | 100% | 3050.01 | 578 / 578 | 97% | 6.09 | 1121 / 1155 |
breast | 100% | 2876.00 | 459 / 459 | 96% | 10.08 | 1073 / 1118 |
skin | 100% | 2274.15 | 1804 / 1809 | 95% | 17.08 | 448 / 472 |
prostate | 100% | 2816.60 | 245 / 245 | 94% | 8.59 | 473 / 502 |
stomach | 100% | 1781.37 | 359 / 359 | 93% | 5.98 | 267 / 286 |
intestine | 100% | 2481.85 | 966 / 966 | 90% | 5.22 | 474 / 527 |
pancreas | 98% | 1315.68 | 323 / 328 | 90% | 4.82 | 161 / 178 |
kidney | 100% | 1994.74 | 89 / 89 | 88% | 7.24 | 792 / 901 |
uterus | 100% | 4172.61 | 170 / 170 | 88% | 5.25 | 402 / 459 |
adrenal gland | 100% | 2772.54 | 258 / 258 | 87% | 4.85 | 199 / 230 |
bladder | 100% | 2635.14 | 21 / 21 | 87% | 5.03 | 436 / 504 |
thymus | 100% | 2700.21 | 653 / 653 | 85% | 4.84 | 515 / 605 |
ovary | 100% | 4604.23 | 180 / 180 | 74% | 2.83 | 320 / 430 |
liver | 100% | 1173.72 | 226 / 226 | 60% | 2.62 | 245 / 406 |
blood vessel | 100% | 2535.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2640.81 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2826.23 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1749.89 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2548.04 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 1405.09 | 789 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 5.33 | 36 / 45 |
eye | 0% | 0 | 0 / 0 | 65% | 5.52 | 52 / 80 |
lymph node | 0% | 0 | 0 / 0 | 55% | 2.45 | 16 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0030100 | Biological process | regulation of endocytosis |
GO_0016197 | Biological process | endosomal transport |
GO_0016050 | Biological process | vesicle organization |
GO_0006622 | Biological process | protein targeting to lysosome |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0031901 | Cellular component | early endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005769 | Cellular component | early endosome |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0005545 | Molecular function | 1-phosphatidylinositol binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZFYVE16 |
Protein name | Zinc finger FYVE-type containing 16 Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein) |
Synonyms | KIAA0305 |
Description | FUNCTION: May be involved in regulating membrane trafficking in the endosomal pathway. Overexpression induces endosome aggregation. Required to target TOM1 to endosomes. . |
Accessions | ENST00000510158.5 [Q7Z3T8-1] ENST00000509562.2 H0YAA4 ENST00000338008.9 [Q7Z3T8-1] D6RC80 Q7Z3T8 H0YAB1 ENST00000507548.1 H0Y8R0 ENST00000513789.1 ENST00000509558.1 ENST00000505560.5 [Q7Z3T8-1] |